Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Capital Expenditures (2016 - 2025)

IGC Pharma has reported Capital Expenditures over the past 15 years, most recently at $29000.0 for Q3 2025.

  • Quarterly Capital Expenditures changed 0.0% to $29000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $82000.0 through Sep 2025, down 45.33% year-over-year, with the annual reading at $112000.0 for FY2025, 18.84% down from the prior year.
  • Capital Expenditures was $29000.0 for Q3 2025 at IGC Pharma, up from $8000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $582000.0 in Q4 2022 and troughed at -$404000.0 in Q3 2022.
  • The 5-year median for Capital Expenditures is $29000.0 (2024), against an average of $48526.3.
  • The largest YoY upside for Capital Expenditures was 2055.56% in 2022 against a maximum downside of 1362.5% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at $27000.0 in 2021, then soared by 2055.56% to $582000.0 in 2022, then plummeted by 88.32% to $68000.0 in 2023, then tumbled by 60.29% to $27000.0 in 2024, then increased by 7.41% to $29000.0 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Capital Expenditures are $29000.0 (Q3 2025), $8000.0 (Q2 2025), and $18000.0 (Q1 2025).